BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
120 results:

  • 1. Cytogenetic abnormalities and TP53 and RAS gene profiles of childhood acute lymphoblastic leukemia in Morocco.
    Skhoun H; El Fessikh M; El Alaoui Al Abdallaoui M; Khattab M; Belkhayat A; Chebihi ZT; Hassani A; Abilkassem R; Agadr A; Dakka N; El Baghdadi J
    Arch Pediatr; 2024 May; 31(4):238-244. PubMed ID: 38679547
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Histiocytic sarcoma following CAR T-cell therapy: a case report.
    An K; He Y; Tang Y; Gu X; Qian J; Li B
    Int J Hematol; 2024 Mar; 119(3):338-341. PubMed ID: 38294639
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
    Kemps PG; Kester L; Scheijde-Vermeulen MA; van Noesel CJM; Verdijk RM; Diepstra A; van Marion AMW; Dors N; van den Bos C; Bruggink AH; Hogendoorn PCW; van Halteren AGS
    Histopathology; 2024 Apr; 84(5):837-846. PubMed ID: 38213281
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
    Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
    Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
    Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
    [No Abstract]    [Full Text] [Related]  

  • 6. [Clinical Analysis of Infants with Acute Lymphoblastic leukemia (18 cases)].
    Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Atypical CML: diagnosis and treatment.
    Breccia M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
    Ramamoorthy S; Lebrecht D; Schanze D; Schanze I; Wieland I; Andrieux G; Metzger P; Hess M; Albert MH; Borkhardt A; Bresters D; Buechner J; Catala A; De Haas V; Dworzak M; Erlacher M; Hasle H; Jahnukainen K; Locatelli F; Masetti R; Stary J; Turkiewicz D; Vinci L; Wlodarski MW; Yoshimi A; Boerries M; Niemeyer CM; Zenker M; Flotho C
    Br J Haematol; 2024 Feb; 204(2):595-605. PubMed ID: 37945316
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
    [No Abstract]    [Full Text] [Related]  

  • 11. Testicular Rosai-Dorfman disease clonally related to CMML - Case report and literature review.
    Fiegl A; Dirnhofer S; Juskevicius D; Zagrapan B; Dertinger S; Bösl A; Milos S; Brunner J; Bertolini F; Offner FA
    Pathol Res Pract; 2023 Jul; 247():154548. PubMed ID: 37216748
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.
    Sendker S; Awada A; Domagalla S; Sendker M; Orhan E; Hoffmeister LM; Antoniou E; Niktoreh N; Reinhardt D; von Neuhoff N; Schneider M
    Leukemia; 2023 Jul; 37(7):1435-1443. PubMed ID: 37188777
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Analysis of 7 cases of pediatric acute myeloid leukemia with DEK-NUP214 fusion gene].
    Li XL; Liu LP; Wan Y; Liu F; Chen X; Ren YY; Ruan M; Guo Y; Zhu XF; Yang WY
    Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):357-362. PubMed ID: 37011983
    [No Abstract]    [Full Text] [Related]  

  • 15. A global study for acute myeloid leukemia with RARG rearrangement.
    Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
    Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
    Prabhakaran N; Jour G; Balar A; Ward N
    Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
    Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
    BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
    González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
    Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
    Larkin KT; Nicolet D; Kelly BJ; Mrózek K; LaHaye S; Miller KE; Wijeratne S; Wheeler G; Kohlschmidt J; Blachly JS; Mims AS; Walker CJ; Oakes CC; Orwick S; Boateng I; Buss J; Heyrosa A; Desai H; Carroll AJ; Blum W; Powell BL; Kolitz JE; Moore JO; Mayer RJ; Larson RA; Stone RM; Paskett ED; Byrd JC; Mardis ER; Eisfeld AK
    Blood Adv; 2022 Oct; 6(19):5570-5581. PubMed ID: 35788257
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection of
    Yao YL; Wang XG; Zhao XL; Li SQ; Zhou YJ; Xu YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):309-313. PubMed ID: 35351263
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.